id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3236590,532d7c3f-36b8-4e88-86f2-bbfe95f3eb9e,Q3,CHAMBER HILL STRATEGIES,400645947,"MAYO COLLABORATIVE SERVICES, INC.",2024,third_quarter,MED,"Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, the VALID Act of 2023; S. 1000/H.R. 2377, the Saving Access to Laboratory Services Act","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2024-10-14T12:03:39-04:00